Cargando…

Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer

Cancer-associated fibroblasts (CAFs) exert a key role in cancer progression and liver metastasis. They are activated in the tumor microenvironment (TME), but their prometastatic mechanisms are not defined. CAFs are abundant in colorectal cancer (CRC). However, it is not clear whether they are raised...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mengxuan, Wei, Zhuang, Feng, Mei, Zhu, Yuanyuan, Chen, Yong, Zhu, Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131873/
https://www.ncbi.nlm.nih.gov/pubmed/34026600
http://dx.doi.org/10.3389/fonc.2021.603556
_version_ 1783694798729773056
author Yang, Mengxuan
Wei, Zhuang
Feng, Mei
Zhu, Yuanyuan
Chen, Yong
Zhu, Di
author_facet Yang, Mengxuan
Wei, Zhuang
Feng, Mei
Zhu, Yuanyuan
Chen, Yong
Zhu, Di
author_sort Yang, Mengxuan
collection PubMed
description Cancer-associated fibroblasts (CAFs) exert a key role in cancer progression and liver metastasis. They are activated in the tumor microenvironment (TME), but their prometastatic mechanisms are not defined. CAFs are abundant in colorectal cancer (CRC). However, it is not clear whether they are raised from local tissue-resident fibroblasts or pericryptal fibroblasts and distant fibroblast precursors, and whether they may stimulate metastasis-promoting communication. B-cell lymphoma 9/B-cell lymphoma 9-like (BCL9/BCL9L) is the key transcription cofactor of β-catenin. We studied the TME of CRC with single-cell sequencing and consequently found that Bcl9 depletion caused a pro-tumor effect of CAFs, while inhibition of abnormal activation of Wnt/β-catenin signal through Bcl9 depletion benefited T-cell–mediated antitumor immune responses. We also identified and evaluated four types of CAFs in CRC with liver metastasis. In summary, we demonstrate cell type landscape and transcription difference upon BCL9 suppression in CAFs, as well as how CAF affects cancer associated immune surveillance by inhibition of Wnt signaling. Targeting the Wnt signaling pathway via modulating CAF may be a potential therapeutic approach.
format Online
Article
Text
id pubmed-8131873
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81318732021-05-20 Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer Yang, Mengxuan Wei, Zhuang Feng, Mei Zhu, Yuanyuan Chen, Yong Zhu, Di Front Oncol Oncology Cancer-associated fibroblasts (CAFs) exert a key role in cancer progression and liver metastasis. They are activated in the tumor microenvironment (TME), but their prometastatic mechanisms are not defined. CAFs are abundant in colorectal cancer (CRC). However, it is not clear whether they are raised from local tissue-resident fibroblasts or pericryptal fibroblasts and distant fibroblast precursors, and whether they may stimulate metastasis-promoting communication. B-cell lymphoma 9/B-cell lymphoma 9-like (BCL9/BCL9L) is the key transcription cofactor of β-catenin. We studied the TME of CRC with single-cell sequencing and consequently found that Bcl9 depletion caused a pro-tumor effect of CAFs, while inhibition of abnormal activation of Wnt/β-catenin signal through Bcl9 depletion benefited T-cell–mediated antitumor immune responses. We also identified and evaluated four types of CAFs in CRC with liver metastasis. In summary, we demonstrate cell type landscape and transcription difference upon BCL9 suppression in CAFs, as well as how CAF affects cancer associated immune surveillance by inhibition of Wnt signaling. Targeting the Wnt signaling pathway via modulating CAF may be a potential therapeutic approach. Frontiers Media S.A. 2021-05-05 /pmc/articles/PMC8131873/ /pubmed/34026600 http://dx.doi.org/10.3389/fonc.2021.603556 Text en Copyright © 2021 Yang, Wei, Feng, Zhu, Chen and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Mengxuan
Wei, Zhuang
Feng, Mei
Zhu, Yuanyuan
Chen, Yong
Zhu, Di
Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer
title Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer
title_full Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer
title_fullStr Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer
title_full_unstemmed Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer
title_short Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer
title_sort pharmacological inhibition and genetic knockdown of bcl9 modulate the cellular landscape of cancer-associated fibroblasts in the tumor-immune microenvironment of colorectal cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131873/
https://www.ncbi.nlm.nih.gov/pubmed/34026600
http://dx.doi.org/10.3389/fonc.2021.603556
work_keys_str_mv AT yangmengxuan pharmacologicalinhibitionandgeneticknockdownofbcl9modulatethecellularlandscapeofcancerassociatedfibroblastsinthetumorimmunemicroenvironmentofcolorectalcancer
AT weizhuang pharmacologicalinhibitionandgeneticknockdownofbcl9modulatethecellularlandscapeofcancerassociatedfibroblastsinthetumorimmunemicroenvironmentofcolorectalcancer
AT fengmei pharmacologicalinhibitionandgeneticknockdownofbcl9modulatethecellularlandscapeofcancerassociatedfibroblastsinthetumorimmunemicroenvironmentofcolorectalcancer
AT zhuyuanyuan pharmacologicalinhibitionandgeneticknockdownofbcl9modulatethecellularlandscapeofcancerassociatedfibroblastsinthetumorimmunemicroenvironmentofcolorectalcancer
AT chenyong pharmacologicalinhibitionandgeneticknockdownofbcl9modulatethecellularlandscapeofcancerassociatedfibroblastsinthetumorimmunemicroenvironmentofcolorectalcancer
AT zhudi pharmacologicalinhibitionandgeneticknockdownofbcl9modulatethecellularlandscapeofcancerassociatedfibroblastsinthetumorimmunemicroenvironmentofcolorectalcancer